UMEM Educational Pearls

We know vancomycin should be dosed based on weight rather than the default 1 gm dose so many patients receive. A past Academic Life in EM post explores the nuances of proper vancomycin dosing. But do higher loading doses in the ED actually lead to more therapeutic trough levels?

New Data

A new randomized trial compared ED patients receiving 30 mg/kg initial doses vs. 15 mg/kg. [1] There was a significantly greater proportion of patients reaching target trough levels of 15 mg/L at 12 hours among the patients who received a 30 mg/kg loading dose as compared with a traditional 15 mg/kg dose (34% vs 3%, P < 0.01). This study did not use a max dose of 2 gm. They included patients up to 120 kg who received 3.6 gm loading doses! Patients with creatinine clearance < 50 mL/min were excluded. There was no difference in incidence of nephrotoxicity between the groups.

Application to Clinical Practice

  • Advocate for change in your ED's order sets to weight-based dosing of vancomycin and remove 1 gm as a default option. [2, 3]
  • While 34% attaininment of adequate trough levels still isn't great, properly loading vancomycin with up to 30 mg/kg is a step in the right direction. It also takes longer than one dose to reach steady-state levels.
  • This study did not evaluate clinical cure rates, just trough levels.

Show References



Title: Drug Abuse Screens

Category: Toxicology

Keywords: Drug Screens, Drug Intervals (PubMed Search)

Posted: 2/5/2015 by Kishan Kapadia, DO
Click here to contact Kishan Kapadia, DO

Performance Characteristics of Common Drug Abuse Screening Immunoassays

Drug/Class

Detection Interval (***)

Comments

Amphetamines

1-2 days (2-4 days)

Decongestants, ephedrine,l-methamphetamine, selegilene & bupropion metabolites may give False (+) results; MDA & MDMA are variably detected

Barbiturates

2-4 days

Phenobarbital may be detected for up to 4 weeks

Benzodiazepines

1-30 days

Benzos vary in reactivityand potency; False (+) results may be seen with oxaprozin

Cannabinoids

1-3 days (>1 month)

Screening assays detect inactive and active cannabinoids; Confirmatory assays detects inactive metabolite THCA (tetrahydrocannabinoic acid)

Cocaine                  

2 days (1 week)

Screening & confirmatory assays detect inactive metabolite BE (benzoylecgonine); False (+) results are unlikely

Opiates

1-2 days; 2-4 days (<1 week)

Semisynthetic opiates derived from morphine show variable cross-reactivity; Fully synthetic opioids (e.g., fentanyl, meperidine, methadone, propoxyphene, tramadol) have minimal cross reactivity; Quinolone may cross-react

Methadone

1-4 days

Doxylamine may cross-react

Phencyclidine

4-7 days (>1 month)

Dextromethorphan, diphenhydramine, ketamine, & venlafaxine may cross react

Propoxyphene

3-10 days

Duration of positivity depends on cross reactivity of metabolite norpropoxyphene

(***)Values are after typical use; values in parentheses are after heavy or prolonged use.

Show References



Title: Measles Update February 2015

Category: International EM

Keywords: Measles, international, pediatrics, vaccination, public health (PubMed Search)

Posted: 2/4/2015 by Jon Mark Hirshon, PhD, MPH, MD
Click here to contact Jon Mark Hirshon, PhD, MPH, MD

From January 1st to January 30th, 2015, 102 people from 14 states were reported to have measles. This one month total is greater than the annual number of U.S. cases from 2002 to 2012.  Most of these cases are related to a large outbreak from a Californian amusement park. Measles can spread in communities without adequate vaccination (low herd immunity). The majority of the people in the US who get measles are unvaccinated. However, measles remains common in many parts of the world.

 

Bottom Line:

As noted in the recent ACEP Fact Sheet, “A very high index of suspicion for Rubeola is necessary especially among patients with an exposure history, travel to foreign or domestic areas where disease is present, and those without adequate immunization. Immediate isolation of these patients should be considered in the ED or other outpatient healthcare setting.”

 

 

Show References

Attachments



Hypertensive Emergency Pearls

  • It is well known that a hypertensive emergency is not defined by an arbitrary blood pressure reading.  Rather, it is characterized by the presence of end-organ dysfunction, often due to a sudden increase in sympathetic activation.
  • When treating patients with a hypertensive emergency, consider the following:
    • Many are hypovolemic due to a pressue-induced natriuresis - give them fluids and avoid diuretics.
    • BP should be reduced in a controlled manner using short-acting titratable intravenous agents. Rapid reductions in BP can lead to organ hypoperfusion.
    • Avoid oral, sublingual, and transdermal medications until end-organ dysfunction has resolved.
    • Clevidipine is the newest agent
      • A third-generation dihydropyridine
      • Relaxes arteriolar smooth muscle
      • Rapid onset (2-4 min) and short acting (5-15 min)
      • Compares favorably with nicardipine in available studies

Show References



Question

Patient presents with right shoulder pain following minor trauma. What's the diagnosis....and what's the Cunningham technique?

Show Answer

Show References



Title: Tetrodotoxin Outbreak - in Minnesota!

Category: Toxicology

Keywords: tetrodotoxin (PubMed Search)

Posted: 1/29/2015 by Fermin Barrueto (Updated: 11/27/2024)
Click here to contact Fermin Barrueto

Tetrodotoxin is lethal poison that blocks sodium channels. A famous sushi called "Fugu" is cut from a puffer fish that contains this poison. The idea is to get just enough of the toxin to cause peri-oral paresthesia but not too much to get seizures, paralysis and cardiac dysrrhythmias. A recent outbreak in Minneapolis, Minnesota was just reported in the MMWR so it can really happen anywhere, its a great read - dried puffer was bought from a market in NYC.

http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6351a2.htm

2-3 mg of the toxin is lethal to an adult human. No antidote exists though I would try hypertonic sodium bicarbonate for the cardiac dysrrhythmias and appropraite supportive. If the patient survives 24 hrs, the patient will do well without sequelae if appropriately supported.

 



Title: Medications in Myasthenia Gravis

Category: Neurology

Keywords: Myasthenia gravis, myopathy, iatrogenic (PubMed Search)

Posted: 1/29/2015 by Danya Khoujah, MBBS
Click here to contact Danya Khoujah, MBBS

Patients with myasthenia gravis (MG) may be seen in the emergency department for symptoms that are not related to their MG, such as an upper respiratory tract infection or chest pain, for example.

The emergency physician should be careful in prescribing new medications to patients with MG, as that can precipitate a myasthenic crisis (and therefore cause significant morbidity and mortality). Below is a list of medications that are commonly implicated; an extensive list can be found on www.myasthenia.org/docs/MGFA_medicationsandmg.pdf)

  • Iodinated IV contrast
  • Fluoroquinolones
  • Aminoglycosides
  • Macrolides
  • IV magnesium replacement
  • Beta blockers (metoprolol and labetalol)

Show References



Title: Extracorporeal Treatment Strategies for Acute Methanol Poisoning (When to Dialyze)

Category: Critical Care

Keywords: Methanol, toxicology, methanol toxicity, critical care (PubMed Search)

Posted: 1/20/2015 by John Greenwood, MD (Updated: 1/30/2015)
Click here to contact John Greenwood, MD

 

Extracorporeal Treatment Strategies for Acute Methanol Poisoning (When to Dialyze)

 

Methanol toxicity is classically included in the differential for the intoxicated patient presenting to the ED. Add a negative EtOH level, anion/osmolar gap, blindness and you have yourself a slam dunk diagnosis. The goal is to stop the liver from metabolizing methanol to formic acid. Outside of fomepizole (or old school ethanol therapy), dialysis is often discussed, but when should you actually get the nephrologist on the phone?

This month the Extracorporeal Treatments in Poisoning Workgroup released a systematic review and consensus statement to help clinicians decide when to pull the HD trigger. Their suggestions are below.

When to start HD:

  1. Neurologic dysfunction: Coma, seizures, new vision deficits
  2. Metabolic acidosis: blood pH ≤7.15 or persistent metabolic acidosis despite adequate supportive measures & antidotes
  3. Serum anion gap higher than 24 mmol/L
  4. Serum methanol concentration:
    • > 700 mg/L (21.8 mmol/L) if fomepizole therapy is given
    • > 600 mg/L or 18.7 mmol/L if ethanol treatment is given
    • > 500 mg/L or 15.6 mmol/L in the absence of an alcohol dehydrogenase blocker

Which Modality: Intermittent HD (IHD) should be used over continuous renal replacement therapies (CRRT), as you can clear the toxin faster with higher HD flows.

When to stop HD: Extracorporeal treatment can be terminated when the methanol concentration is less than 200 mg/L or 6.2 mmol/L and a clinical improvement is observed.

Bottom Line:  Consider early hemodialysis in most patients presenting with methanol toxicity.  Clinical exam and routine lab testing will likely provide enough information to determine the need for IHD, but specific methanol levels can be helpful to guide adjunctive treatment options.

 

Reference

Roberts DM, Yates C, Megarbane B, et al. Recommendations for the Role of Extracorporeal Treatments in the Management of Acute Methanol Poisoning: A Systematic Review and Consensus Statement. Crit Care Med. 2015;43(2):461-472.

 

Follow me on Twitter @JohnGreenwoodMD

 



Question

Elderly male presents with the skin findings below. He is also on a medication for atrial fibrillation. What's the diagnosis?

Show Answer

Show References



Posterior Myocardial Infarctions (PMI)

- Posterior myocardial infarctions (PMI) are different than typical ST-elevation MI; the ECG findings include: septal & anterior ST-segment depression, dominant tall/broad R waves, and upright T waves.

- In a study among 117,739 subjects with STEMI, 824 with PMI were more likely to present with cardiac arrest, cardiogenic shock, and congestive heart failure.

- The median time from arrival ECG to revascularization with PCI was longer among subjects with PMI.

- The median time from arrival ECG to systemic thrombolysis was also longer among subjects with a PMI.

- Increased awareness and recognition of PMI is needed to improve reperfusion times among this subpopulation with STEMI.

 

Show References



Title: Calcaneal stress fractures

Category: Orthopedics

Keywords: Heel pain, bone injury (PubMed Search)

Posted: 1/24/2015 by Brian Corwell, MD
Click here to contact Brian Corwell, MD

Overuse injury

Seen in runners, military recruits (marching), ballet dancers and in jumping sports (heavy landing).

Insidious onset of heel pain, that is worse with jumping then running then later with simple weight bearing.

Tenderness to palpation posteriorly (medially or laterally), and squeezing bilateral posterior calcaneus.

Testing:

XR: May not be positive for 2 to 4 weeks. Sclerotic appearance (vertically oriented) posterior calcaneus.

MRI: high signal T2 at fracture site.

DDx: plantar fasciitis.

Treatment: Reduction of activity if Sxs mild, for severe pain start a trial of non weight-bearing (boot or splint with crutches).

Stretching of calf, achilles, plantar fascia.



Title: Multidrug Resistant Tuberculosis (MDR TB)

Category: International EM

Keywords: Tuberculosis, infectious disease, drug resistance, multidrug resistant tuberculosis (PubMed Search)

Posted: 1/21/2015 by Jon Mark Hirshon, PhD, MPH, MD
Click here to contact Jon Mark Hirshon, PhD, MPH, MD

As noted previously (UMEM Pearl of 1/7/2015), tuberculosis (TB) is a major infectious disease that occurs worldwide. Strains of tuberculosis can be resistant to one or more anti-tuberculosis medications. TB strains resistant to at least one medication have been found in all surveyed countries.

 

What is multidrug-resistant tuberculosis (MDR TB)?

  • A TB organism resistant to at least isoniazid and rifampin
    • Two of the most common, potent and standard TB medications
  • Primary cause of MDR TB is inappropriate or incorrect usage of TB medications
  • In 2013, there were approximately 480,000 cases of MDR TB globally
    • Most cases were in India, China and the Russian Federation
  • A concerning form of resistant TB is extensively drug resistant TB (XDR TB), which is resistant to multiple anti-tuberculosis medications (see UMEM Pearl from 8/14/2013).

 

Treatment of MDR TB

  • MDR TB can usually be treated and cured with second-line treatments
  • Use of second-line treatments tend to be more:
    • Difficult to access the medications
    • Expensive
    • Likely to produce severe adverse reactions

 

Bottom line:

As noted previously, in your emergency department have a high index of suspicion for TB and MDR TB in patients with an appropriate risk profile.

  • Recent travel from appropriate countries
    • Most TB cases/deaths are in developing countries
  • Individuals infected with HIV.
  • Individuals using tobacco
    • Increases the risk of infection and death from TB.
  • Any age group, including children
    • Mostly affects young adults in their productive years

Show References



  • Intraosseous (IO) is well-recognized as a venous line for delivering a variety of medications, including vasopressors. However, there is not a wealth of literature to support the use of IOs when administering medications for rapid sequence intubation (RSI).
  • This prospective observational study was conducted to determine whether an IO can be used to reliably and rapidly administers medications during RSI in trauma patients.
  • Thirty-four trauma patients were enrolled in the study and patients had a variety of traumatic mechanisms; blunt, penetrating, burns, and blast. The primate study outcome was the success rate of first-pass intubations using direct laryngoscopy.
  • The authors demonstrated a first pass success rate of 97% with a grade I view on 91% of attempts.
  • Bottom-line: This is yet another study demonstrating that when rapid and reliable access is needed, IO is an excellent option for venous access.

Show References



Question

60 year-old male presents with 6 months of weight loss,epistaxis, and increased headache when bending over. What's the diagnosis?

Show Answer

Show References



Of pediatric patients who have anteroposterior (AP) pelvic xrays (XR), there is a 4.6% rate of pelvic fracture or dislocation, compared to 10% in adults.

This study is a sub analysis of a prospective observational cohort of children with blunt torso trauma conducted by PECARN. 7808 patients had pelvic imaging, with 65% of them having an AP XR. The XR sensitivity ranged from 64-82% (based on age groups) for detecting fractures. All but one patient with a pelvic fracture not detected on XR had a CT scan. The CT scan detected all but 2 fractures both of which were picked up later as healing fractures on repeat pelvic XR. Some of the patients who had a missed fracture on XR were hemodynamically unstable or wound up requiring operative intervention.

The authors support the following algorithm:

-With hemodynamically unstability children, obtain a pelvic XR

-For hemodynamically stable children when the physician is planning to get a CT, there is no indication for XR

Bottom line: Consider using AP pelvic radiographs in the hemodynamically stable patient with a high suspicion for fracture or dislocation who are not undergoing CT.

Show References



Left Ventricular Hypertrophy & Arrhythmias: Any Association?

Associations between left ventricular hypertrophy (LVH) and both supraventricular (SVT)/ventricular arrhythmias (VT/VF) have previously been reported.

A recent review & meta-analysis of 10 studies (27,141 patients) revealed the following:

    - Incidence of SVT was 11% with LVH compared to 1% without (p <0.001)

    - LVH patients had 3.4-fold greater odds of developing SVT

    - Incidence of VT/VF was 5.5% with LVH compared to 1.2% without (p <0.001)

    - LVH patients has 2.8 greater odds of developing VT/VF

The reason for increased arrhythmogenicity in LVH is not clearly understood.

A consistently observed abnormality in LVH is non-uniform propagation of the action potential throughout the myocardium, which sets the stage for arrhythmias based on early or delayed afterdepolarizations.

Given the heterogeneity in this meta-analysis further research between LVH & sustained arrhythmias is needed to infer true causality.

Show References



Title: Causes of Heel Pain

Category: Orthopedics

Keywords: heel, pain, causes (PubMed Search)

Posted: 1/17/2015 by Michael Bond, MD (Updated: 11/27/2024)
Click here to contact Michael Bond, MD

We often think of Plantar Fascitis as the cause of heel pain but there are a lot of other causes. Some of those include:



Title: Can Hydroxocobalamin be administered via intraosseous access for acute cyanide toxicity?

Category: Toxicology

Keywords: intraosseous, hydroxocobalamin, cyanide poisoning (PubMed Search)

Posted: 1/15/2015 by Hong Kim, MD (Updated: 11/27/2024)
Click here to contact Hong Kim, MD

Hydroxocobalamin is an effective cyanide antidote when administered intravenously. Although intraosseous (IO) access is often used in critically ill patients with difficult or delayed IV access, the efficacy of IO administration has not been investigated until recently.

In a recent randomized animal study, acute cyanide toxicity was induced in two groups of swine where 150 mg/kg Hydroxocobalamin was administered via IV vs. IO. The survival rate, reversal of hypotension, and laboratory results were similar between the IV and IO group.

The finding of this study suggest that IO administration of Hydroxocobalamin is as efficacious as IV administration and its administration in acute cyanide toxicity should not be delayed due to lack of IV access when IO access is available.

Show References



Title: Is progesterone yet another disappointing neuroprotectant?

Category: Neurology

Keywords: traumatic brain injury, progesterone, neuroprotectant, clinical trials, PROTECT III, SYNAPSE (PubMed Search)

Posted: 1/14/2015 by WanTsu Wendy Chang, MD
Click here to contact WanTsu Wendy Chang, MD

 

Is progesterone yet another disappointing neuroprotectant?

Traumatic brain injury (TBI) affects more than 1.7 million persons in the U.S. annually.  The incidence of TBI is increasing globally, especially in developing countries.  Despite improvement in trauma systems and critical care, the morbidity and mortality associated with severe TBI remain high.

Progesterone has been shown in preclinical and phase 2 randomized clinical trials to have pluripotent neuroprotective properties and improve mortality in TBI.

 

Two multicenter phase 3 trials were recently completed and published in the December 25th issue of the New England Journal of Medicine.  However, their results were disappointing.

  • The Progesterone for the Treatment of Traumatic Brain Injury (PROTECT III) trial, funded by the NIH, looked at progesterone administered within 4 hours after injury in patients with moderate to severe TBI.
  • The Study of a Neuroprotective Agent, Progesterone, in Severe Traumatic Brain Injury (SYNAPSE) trial, funded by BHR Pharma, looked at progesterone administered within 8 hours after injury in patients with severe TBI.

Both studies used the Glasgow Outcome Scale (GOS) or Extended Glasgow Outcome Scale (GOS-E) at 6 months as their primary outcome.  The GOS and GOS-E capture the degree of recovery from brain injury in terms of disability, stratified into levels by death, vegetative state, severe disability, moderate disability, and good recovery.

Progesterone was not found to have any benefit in functional outcome at 6 months.

 

Both of these studies were well designed and conducted.  However, they were based on small effect sizes of the phase 2 trials.  In addition, they had very favorable outcome rates in the placebo group, thereby making it hard to demonstrate a benefit by their sample sizes.

There has been a long history of failed neuroprotectant trials likely due to the complex and variable injury mechanisms involved in TBI.  The currently available outcome measures are also insensitive to the targeted mechanistic endpoints.  More research is needed to understand not only potential therapies but also how to select appropriate patients for these therapies.

 

Take Home Point:  Progesterone does not have any clear benefit in TBI at this time.

 

Show References



Title: Diaphragm weakness and its significance

Category: Critical Care

Keywords: diaphragm weakness, respiratory failure (PubMed Search)

Posted: 1/13/2015 by Feras Khan, MD
Click here to contact Feras Khan, MD

Diaphragm weakness and its significance

  • Acute respiratory failure is partially due to respiratory muscles inability to meet the demands of respiration that is strained by a medical condition
  • Ventilation can have an adverse effect on respiratory muscles even after just 5-6 days (atrophy)

There are several ways to monitor diaphragm strength and function

  • Airway pressure and flow waveforms
  • Occlusion pressure
  • Esophageal pressure waveforms
  • Sniff maneuvers
  • Ultrasound
  • Diaphragm EMG
  • Chest xray

Clinical Relevance

  • Goal is to use these devices to limit the development of respiratory muscle atrophy because of disuse
  • Prevent "overassist" from the ventilator
  • Potential use in weaning trials to evaluate for respiratory muscle performance
  • This is a new area of intensive care research that could lead to improvements in outcomes

Show References